Patents Assigned to The General Hopital Corporation
  • Method of regulating immune function
    Patent number: 6075020
    Abstract: Disclosed herein is a method of treating an immune system dysfunction in a mammal by administering a prolactin reducer and a prolactin enhancer at a predetermined time or times.
    Type: Grant
    Filed: December 3, 1998
    Date of Patent: June 13, 2000
    Assignees: The General Hopital Corporation, The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Anthony H. Cincotta, Albert H. Meier